Piramal Pharma Exercises Call Option For 41% Yapan Stake

10 August 2026

Piramal Pharma Ltd.

Develops processes, characterizes, and manufactures vaccines and biologics under GMP.

Recent Events

Piramal Pharma Receives Form 483 With Seven Observations For Morpeth Facility

Piramal Pharma Recreates Pledge Over 98.4 Million Shares

Piramal Pharma Reports Release Of 7.39% Share Pledge

Piramal Pharma Secures US FDA EIR For Sellersville Facility

Get features of